By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Bridge to New Markets.

Pfizer invests EUR 54 million in Austrian-based research

Pfizer building in Viennna © Pfizer

New medicines are being developed in cooperation with local medical universities, research institutions and hospitals. Clinical research carried out by Pfizer focuses on new treatments for cancer, chronic-inflammatory diseases, cardiovascular diseases, rare diseases, pain and new vaccines. In 2017 Pfizer also invested EUR 54 million in Austria.

One example of the company’s cooperation in the field of clinical research is its partnership with the academic institution ABCSG. The study group led by Prof. Michael Gnant (Medical University of Vienna) heads a registration trial with a substance developed by Pfizer to treat breast cancer. The study is completely financed by Pfizer and ABCSG is in charge of data, patient and project management in 21 countries across the globe. 5,600 patients are to take part in the study over a period of fifteen years. 18 hospitals and about 500 patients are involved just in Austria. „The fact that responsibility for a globally implemented Phase III study is in Austrian hands is a nice acknowledgement of the longstanding work done by ABCSG”, explains Prof. Gnant, President of ABCSG.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Business Jump for Hungarian Startups and ScaleUps– Expert Speed dating (Loffice Budapest and ABA)

    16.06.2021/ 9.00am (CET), Online Conference

  • Smart Manufacturing and Artificial Intelligence in Austria

    5.08.2021/15.00 CST (China Standard Time), Virtual Event

Austria Map

Find the perfect location for your company

Reliability and expertise in the country and in the company are the convincing factors in selecting a business location. We can be justifiably proud but can still become even more attractive. This is something Austria should increasingly work on in the future!

Pfizer

Logo
More testimonials

news from the business location Austria

"There’s just no room for nostalgia or clinging to the way things have been."

Chris Messina (Product developer for Google & Uber and the inventor of the hashtag) on the culture of failure, Silicon Valley and why "that's how it has always been done" might be a dangerous mindset. Interview by Marianna Bonechi (ABA Consultant San Francisco).

Bosch successfully pushes ahead with innovations in Austria

As a leading global supplier of technology and services, the Bosch Group offers technology that is “invented for life”. Thanks to its products and services that are innovative and spark enthusiasm, Bosch improves the quality of life for people worldwide. The innovative strength of the company is the basis for future growth.

More news All blog posts